CD63-EP211

Melanoma stained with anti-CD63

CD63-EP211

CD63 is a 53 kDa lysosomal membrane glycoprotein that has been identified as a platelet activation molecule that belongs to the tetraspanin family, which is characterized by the presence of four hydrophobic domains. CD63 can mediate signal transduction events that play a role in the regulation of cellular adhesion, cell differentiation, migration, carcinogenesis, and tumor progression. CD63 shows a broad tissue distribution and is predominantly localized in cytoplasmic lysosomes. It is mainly present on platelet lysosomes, granulocytes, basophils, and a small percentage of resting T-cells, while it is also strongly expressed in early melanoma, breast carcinoma, merkel cell carcinoma, astrocytoma, and lung adenocarcinoma.  Recent reports also indicate that CD63 is a good prognostic biomarker for human astrocytomas and earlier stages of lung carcinoma. Additionally, CD63 has been useful in differentiating renal oncocytomas (RO) from eosinophilic variants of chromophobe renal cell carcinomas (RCCs).

  • Description
  • Specifications
  • Ordering Information

CD63 is a 53 kDa lysosomal membrane glycoprotein that has been identified as a platelet activation molecule that belongs to the tetraspanin family, which is characterized by the presence of four hydrophobic domains. CD63 can mediate signal transduction events that play a role in the regulation of cellular adhesion, cell differentiation, migration, carcinogenesis, and tumor progression. CD63 shows a broad tissue distribution and is predominantly localized in cytoplasmic lysosomes. It is mainly present on platelet lysosomes, granulocytes, basophils, and a small percentage of resting T-cells, while it is also strongly expressed in early melanoma, breast carcinoma, merkel cell carcinoma, astrocytoma, and lung adenocarcinoma.  Recent reports also indicate that CD63 is a good prognostic biomarker for human astrocytomas and earlier stages of lung carcinoma. Additionally, CD63 has been useful in differentiating renal oncocytomas (RO) from eosinophilic variants of chromophobe renal cell carcinomas (RCCs).

  • Source
    Rabbit Monoclonal
  • Clone
    EP211
  • Class
    IVD
  • Isotype
    Rabbit IgG
  • Tested Reactivity
    Human,FFPE
  • Localization
    Membranous, Cytoplasmic
  • Positive Control
    Spleen, Melanoma, Tonsil
  • Catalog
    Pack Size
  • PR024-3ml
    3 ml(RTU)
  • PR024-6ml
    6 ml(RTU)
  • CR024-0.1ml
    0.1 ml(Conc.)
  • CR024-0.5ml
    0.5 ml(Conc.)
  • HAR024-3ml
    3 ml(RTU)
  • HAR024-6ml
    6 ml(RTU)
  • CR024 - 1ml
    1ml ( Conc. )